التفاصيل البيبلوغرافية
| العنوان: |
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma |
| المؤلفون: |
Alexander M.M. Eggermont, Michal Kicinski, Christian U. Blank, Mario Mandala, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Paul Lorigan, Dmitri Grebennik, Clemens Krepler, Sandrine Marreaud, Stefan Suciu, Caroline Robert |
| المصدر: |
NEJM Evidence. 1 |
| بيانات النشر: |
Massachusetts Medical Society, 2022. |
| سنة النشر: |
2022 |
| تدمد: |
2766-5526 |
| الوصول الحر: |
https://explore.openaire.eu/search/publication?articleId=doi_________::0db10bc82d7503837ae113bd1fe22dc8Test
https://doi.org/10.1056/evidoa2200214Test |
| رقم الانضمام: |
edsair.doi...........0db10bc82d7503837ae113bd1fe22dc8 |
| قاعدة البيانات: |
OpenAIRE |
